H.R. 10857

To amend the Federal Food, Drug, and Cosmetic Act and Public Health Service Act to advance the next-generation of clinical development of novel treatments and cures, and for other purposes.

1 cosponsor

H. Morgan Griffith

Where it stands

Introduced Oct 22
Committee Now
House of Representatives —
Senate —
Law —

Introduced Oct 22
Committee Now
House of Representatives —
Senate —
Law —

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (Oct 22)

Votes

No roll-call votes yet.

Official summary

No official summary yet.

Text of the bill

No text published yet.